Martin Burke (CorVita Science Foundation, Chicago, USA) presents the preclinical acute and chronic performance of the combined implant of a leadless anti-tachycardia pacemaker and subcutaneous implantable cardioverter defibrillator (S-ICD). The results have shown appropriate VVI functionality, successful wireless device-device communication and anti-tachycardia pacing delivery by the leadless pacemaker. The chronic data were first presented at the Heart Rhythm Congress (9‒12 October, Birmingham, UK) and followed-up acute results presented at the 2016 Heart Rhythm Society Scientific Sessions and CARDIOSTIM EHRA-EUROPACE.
<>
